OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
45
Views
3
CrossRef citations to date
0
Altmetric
Original Research
RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia
Fang Liu1 Department of Oncology, Chinese PLA General HospitalCorrespondence[email protected]
, Ming Gong2 Department of Hematology, China-Japan Friendship Hospital
, Li Gao2 Department of Hematology, China-Japan Friendship Hospital
, Xiaoping Cai3 Department of Geriatric Medicine, Army General Hospital, Beijing, People’s Republic of China
, Hui Zhang2 Department of Hematology, China-Japan Friendship Hospital
& Yigai Ma2 Department of Hematology, China-Japan Friendship HospitalCorrespondence[email protected]
Pages 4143-4151
|
Published online: 22 Aug 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.